Response of resting human peripheral blood natural killer cells to interleukin 2
暂无分享,去创建一个
G. Trinchieri | B. Perussia | S. Clark | J. Seehra | L. London | M. Matsumoto-Kobayashi | S. C. Clark | B. Perussia | G. Trinchieri | J. Seehra | L. London
[1] G. Trinchieri,et al. The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. , 1984, Journal of immunology.
[2] B. V. van Krimpen,et al. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells. , 1984, Journal of immunology.
[3] E. Brown,et al. Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Doyle,et al. Biological activity of recombinant human interleukin-2 produced in Escherichia coli. , 1984, Science.
[5] S. Baron,et al. Interleukin 2 enhances natural killing of normal lymphocytes. , 1984, Cellular immunology.
[6] G. Trinchieri,et al. The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood. , 1984, Journal of immunology.
[7] G. Trinchieri,et al. Antibody 3G8, specific for the human neutrophil Fc receptor, reacts with natural killer cells. , 1984, Journal of immunology.
[8] R. Mertelsmann,et al. Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2. , 1984, Cellular immunology.
[9] C. Li. [T cell growth factor]. , 1984, Sheng li ke xue jin zhan [Progress in physiology].
[10] 宮坂 信之. Interleukin 2 enhances natural killing of normal lymphocytes , 1984 .
[11] G. Pantaleo,et al. Assignment of human natural killer (NK)‐like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK‐sensitive target cells via distinct recognition structures , 1984, European journal of immunology.
[12] F. Sánchez‐Madrid,et al. A human leukocyte differentiation antigen family with distinct alpha- subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule , 1983, The Journal of experimental medicine.
[13] D. Cantrell,et al. Transient expression of interleukin 2 receptors. Consequences for T cell growth , 1983, The Journal of experimental medicine.
[14] C. Henney,et al. Interleukin 2 is not sufficient for the continuous growth of cloned NK-like cytotoxic cell lines. , 1983, Journal of immunology.
[15] T. Waldmann,et al. Characterization of the human receptor for T-cell growth factor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[16] E. Reinherz,et al. Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function , 1983, The Journal of experimental medicine.
[17] C. Balch,et al. Interleukin 2 receptor expression by activated HNK-1+ granular lymphocytes: a requirement for their proliferation. , 1983, Journal of immunology.
[18] G F Babcock,et al. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. , 1983, Journal of immunology.
[19] H. Teh,et al. Activation of nonspecific killer cells by interleukin 2-containing supernatants. , 1983, Journal of immunology.
[20] D. Weigent,et al. Interleukin 2 enhances natural killer cell activity through induction of gamma interferon , 1983, Infection and immunity.
[21] K. Welte,et al. Purified human interleukin-2 enhances induction of immune interferon. , 1983, Cellular immunology.
[22] I. Kawase,et al. Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells. , 1983, Journal of immunology.
[23] G. Trinchieri,et al. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane. , 1983, Journal of immunology.
[24] G. Trinchieri,et al. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. , 1983, Journal of immunology.
[25] S. Rosenberg,et al. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells , 1983, The Journal of experimental medicine.
[26] R. Suzuki,et al. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production. , 1983, Journal of immunology.
[27] R. Suzuki,et al. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells. , 1983, Journal of immunology.
[28] E. Shevach,et al. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses. , 1983, Journal of immunology.
[29] C. Riccardi,et al. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. II. Regulatory role of interferon on proliferative and cytotoxic precursors. , 1983, Journal of immunology.
[30] B. Dupont,et al. Cell surface phenotype of a cloned line of human natural killer cells. , 1982, Journal of immunology.
[31] N. Sidell,et al. Interleukin 2 and stimulator lymphoblastoid cells will induce human thymocytes to bind and kill K562 targets , 1982, The Journal of experimental medicine.
[32] D. Kraft,et al. A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes. , 1982, Journal of Immunology.
[33] K. Zoon,et al. Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses , 1982, The Journal of experimental medicine.
[34] C. Y. Wang,et al. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity , 1982, The Journal of experimental medicine.
[35] S. Rosenberg,et al. Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.
[36] C. Balch,et al. Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody. , 1982 .
[37] G. Trinchieri,et al. PHENOTYPIC CHARACTERIZATION OF HUMAN NATURAL KILLER AND ANTIBODY-DEPENDENT KILLER CELLS AS AN HOMOGENEOUS AND DISCRETE CELL SUBSET , 1982 .
[38] C. Henney,et al. IN VIVO INTERLEUKIN-2 INDUCED AUGMENTATION OF NATURAL KILLER CELL ACTIVITY , 1982 .
[39] A. Munck,et al. T cell growth factor receptors. Quantitation, specificity, and biological relevance , 1981, The Journal of experimental medicine.
[40] G. Trinchieri,et al. Terminal differentiation surface antigens of myelomonocytic cells are expressed in human promyelocytic leukemia cells (HL60) treated with chemical inducers. , 1981, Blood.
[41] C. Balch,et al. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). , 1981, Journal of immunology.
[42] C. Henney,et al. Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. , 1981, Journal of immunology.
[43] C. Henney,et al. Interleukin-2 augments natural killer cell activity , 1981, Nature.
[44] P. Krammer,et al. Production of immune interferon by murine T-cell clones from long-term cultures , 1981, Nature.
[45] E. Larsson. Mechanism of T cell activation. II. Antigen- and lectin-dependent acquisition of responsiveness to TCGF is a nonmitogenic, active response of resting T cells. , 1981, Journal of immunology.
[46] T. Waldmann,et al. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. , 1981, Journal of immunology.
[47] W. Farrar,et al. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. , 1981, Journal of immunology.
[48] M. Ullberg,et al. Recycling and target binding capacity of human natural killer cells , 1981, The Journal of experimental medicine.
[49] G. Dennert,et al. Cloned cell lines with natural killer activity. Specificity, function, and cell surface markers , 1981, The Journal of experimental medicine.
[50] G. Trinchieri,et al. Inactivation of natural killer cell cytotoxic activity after interaction with target cells. , 1981, Journal of immunology.
[51] J. Blalock,et al. Transmission of IFN-induced activities by cell to cell communication. , 1981, Texas reports on biology and medicine.
[52] G. Trinchieri,et al. Functional studies of Fc receptor-bearing human lymphocytes: effect of treatment with proteolytic enzymes. , 1979, Journal of immunology.
[53] K. Smith,et al. Monoclonal cytolytic T-cell lines , 1979, The Journal of experimental medicine.
[54] R. Gallo,et al. Selective in vitro growth of T lymphocytes from normal human bone marrows. , 1976, Science.
[55] G. Trinchieri,et al. Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A. , 1973, Transplantation proceedings.
[56] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[57] Stern Bt,et al. EXCERPTA MEDICA. , 1974, Canadian Medical Association journal.
[58] M. Krogh. Colloidal Chemistry and Immunology , 1916 .